Researchers discover novel candidate drug targets for advanced non-alcoholic fatty liver disease


Using the latest technologies-;including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells-;researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD).

New findings and recommendations to combat the EVALI epidemic

Previous article

Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News